INJIL ABU BAKAR
Allopathic & Osteopathic Physicians|Family Medicine PLYMOUTH, MA NPI 1013095041
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine MA PFIZER INC. All categories
General Payments — all program years on this page
$209.93
- Category: General Payments
- Program years: PY2022–2024
- Record count: 9
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $193.54 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $193.54 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $55.64 | 2 |
| Novo Nordisk AS | $35.03 | 2 |
| Mylan Specialty L.P. | $31.21 | 1 |
| Otsuka America Pharmaceutical, Inc. | $26.18 | 1 |
| Exact Sciences Corporation | $25.13 | 1 |
| Amgen Inc. | $20.35 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1096954420 | Novo Nordisk Inc | $17.16 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097339605 | Novo Nordisk Inc | $17.87 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111508783 | Amgen Inc. | $20.35 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1114568649 | Exact Sciences Corporation | $25.13 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118847686 | Otsuka America Pharmaceutical, Inc. | $26.18 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131400666 | PFIZER INC. | $30.80 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131772861 | PFIZER INC. | $24.84 | 07/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147380666 | Mylan Specialty L.P. | $31.21 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.